SEC Form 4 · accession 0001493152-26-027587
Sanara MedTech Inc. · SMTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roszell Mack III
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 8:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000714256
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 4, 2026 | A | 5,308 | $0.00 | A | 21,842 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.